Petros Pharmaceuticals Inc (PTPI)
0.6354
+0.05
(+8.54%)
USD |
NASDAQ |
May 31, 16:00
0.6643
+0.03
(+4.55%)
After-Hours: 20:00
Petros Pharmaceuticals Debt to Equity Ratio: 0.7494 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.7494 |
December 31, 2023 | 0.6421 |
September 30, 2023 | 1.189 |
June 30, 2023 | 0.6765 |
March 31, 2023 | 0.5904 |
December 31, 2022 | 0.5674 |
September 30, 2022 | 0.4669 |
Date | Value |
---|---|
June 30, 2022 | 0.293 |
March 31, 2022 | 0.2856 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.0975 |
June 30, 2021 | 0.1757 |
March 31, 2021 | 0.2419 |
December 31, 2020 | 0.4107 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
1.189
Maximum
Sep 2023
0.4561
Average
0.4388
Median
Debt to Equity Ratio Benchmarks
Avalo Therapeutics Inc | -- |
Imunon Inc | -- |
iBio Inc | -- |
Ocugen Inc | 0.0935 |
Gritstone Bio Inc | 2.888 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 30.31M |
Total Liabilities (Quarterly) | 19.62M |
Shareholders Equity (Quarterly) | 10.69M |
Current Ratio | 1.596 |
Net Debt Paydown Yield | 2.87% |